{"id":204392,"name":"PEAR THERAPEUTICS, INC.","slug":"pear-therapeutics-inc","state":"MA","country":"United States of America","description":"Development of prescription digital therapeutics.","totalSpending":480000,"filings":13,"yearlySpending":[{"year":2020,"income":180000},{"year":2021,"income":160000},{"year":2022,"income":120000},{"year":2023,"income":20000}],"issues":["HCR"],"firms":["K&L GATES, LLP"],"lobbyists":["SCOTT ALIFERIS","SCOTT NELSON","DENNIS POTTER","PAMELA GARVIE","DANIEL RITTER","STEVEN VALENTINE","BART GORDON","W STEPHENS","DARRELL CONNER","AMY CARNEVALE","VICTORIA HAMSCHO","SEAN MCGLYNN","JEFFREY DENHAM","BRENDEN CHAINEY","SARAH SWANSON","SCOTT GELBMAN","MICHAEL EVANS"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","White House Office","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Issues related to prescription digital therapeutics including S. 3532 - Prescription Digital Therapeutics to Support Recovery Act.","Issues related to prescription digital therapeutics including S. 3552 - Prescription Digital Therapeutics to Support Recovery Act.","Issues related to prescription digital therapeutics including S. 3552 - Prescription Digital Therapeutics to Support Recovery Act.","Issues related to prescription digital therapeutics including S. 3552 - Prescription Digital Therapeutics to Support Recovery Act.","Federal policy related to prescription digital therapeutics (no specific legislation)."],"years":[2020,2021,2022,2023]}